Author:
Tsoi Kelvin K.F.,Chan Joyce Y.C.,Leung Nelson W.Y.,Hirai Hoyee W.,Wong Samuel Y.S.,Kwok Timothy C.Y.
Subject
Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology
Reference39 articles.
1. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine;Zemek;Expert Opin Drug Saf,2014
2. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial;Tariot;JAMA,2004
3. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial;Porsteinsson;Curr Alzheimer Res,2008
4. National Institute for Clinical Excellence (NICE). Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease. Issued: March 2011. London, England: National Institute for Clinical Excellence (NICE).
5. Memantine in Alzheimer's Disease. Executive Summary of Final Report A05e19C,2009
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献